Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The veteran's residuals of prostate cancer, status post IMRT are rated as a 20 percent evaluation for urinary frequency. The Board also granted special monthly compensation (SMC) based on loss of use of a creative organ.

The deciding factor: The veteran's residuals of prostate cancer resulted in urinary frequency and urgency that required a compensable rating of 20 percent, with no evidence of obstructed voiding or other severe residuals. The SMC was granted as the veteran has suffered anatomical loss due to his service-connected disability.

Claimed conditions
prostate cancer
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
20%
Decision date
September 29, 2008
Citation
0833269

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 0833269.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.